[1]
|
张维, 李奇穗, 邓长刚, 黄薇, 孙艳雨, 袁婧. 重庆地区HIV感染者和AIDS患者合并恶性肿瘤疾病谱分析[J]. 中国预防医学杂志, 2021, 22(10): 752-756.
|
[2]
|
甘清鑫, 刘晋新. 艾滋病合并恶性肿瘤[J]. 新发传染病电子杂志, 2016, 1(1): 53-55.
|
[3]
|
Goncalves, P.H., Montezuma-Rusca, J.M., Yarchoan, R. and Uldrick, T.S. (2016) Cancer Pre-vention in HIV-Infected Populations. Seminars in Oncology, 43, 173-188. https://doi.org/10.1053/j.seminoncol.2015.09.011
|
[4]
|
Chang, Y., Cesarman, E., Pessin, M.S., et al. (1994) Identi-fication of Herpesvirus-Like DNA Sequences in AIDS-Sssociated Kaposi’s Sarcoma. Science, 266, 1865-1869. https://doi.org/10.1126/science.7997879
|
[5]
|
Dupin, N. (2020) Update on Oncogenesis and Therapy for Kaposi Sarcoma. Current Opinion in Oncology, 32, 122-128.
https://doi.org/10.1097/CCO.0000000000000601
|
[6]
|
Coscoy, L. and Ganem, D. (2000) Kaposi’s Sar-coma-Associated Herpesvirus Encodes Two Proteins That Block Cell Surface Display of MHC Class I Chains by En-hancing Their Endocytosis. Proceedings of the National Academy of Sciences of the United States of America, 97, 8051-8056. https://doi.org/10.1073/pnas.140129797
|
[7]
|
Coscoy, L., Sanchez, D.J. and Ganem, D. (2001) A Novel Class of Herpesvirus-Encoded Membrane-Bound E3 Ubiquitin Ligases Regulates Endocytosis of Proteins In-volved in Immune Recognition. Journal of Cell Biology, 155, 1265-1273. https://doi.org/10.1083/jcb.200111010
|
[8]
|
Karabajakian, A., Ray-Coquard, I. and Blay, J.Y. (2022) Molecular Mechanisms of Kaposi Sarcoma Development. Cancers, 14, Article No. 1869. https://doi.org/10.3390/cancers14081869
|
[9]
|
Jary, A., Veyri, M., Gothland, A., et al. (2021) Kaposi’s Sar-coma-Associated Herpesvirus, the Etiological Agent of All Epidemiological Forms of Kaposi’s Sarcoma. Cancers, 13, Article No. 6208. https://doi.org/10.3390/cancers13246208
|
[10]
|
Vangipuram, R. and Tyring, S.K. (2019) AIDS-Associated Malignancies. In: Meyers, C., Ed., HIV/AIDS-Associated Viral Oncogenesis. Cancer Treatment and Research, Vol. 177, Springer, Cham, 1-21.
https://doi.org/10.1007/978-3-030-03502-0_1
|
[11]
|
Royse, K.E., El Chaer, F., Amirian, E.S., et al. (2017) Dispari-ties in Kaposi Sarcoma Incidence and Survival in the United States: 2000-2013. PLOS ONE, 12, e0182750. https://doi.org/10.1371/journal.pone.0182750
|
[12]
|
Jary, A., Gothland, A., Palich, R., et al. (2021) Poppers, by In-ducing HHV-8 Virion Production, Can Act as a Promoter for HHV-8 Transmission in Men Who Have Sex With Men. Open Forum Infectious Diseases, 8, Article ID: ofab166.
https://doi.org/10.1093/ofid/ofab166
|
[13]
|
Lodi, S., Guiguet, M., Costagliola, D., et al. (2010) Kaposi Sarcoma In-cidence and Survival among HIV-Infected Homosexual Men after HIV Seroconversion. Journal of the National Cancer Institute, 102, 784-792.
https://doi.org/10.1093/jnci/djq134
|
[14]
|
Maurer, T., Ponte, M. and Leslie, K. (2007) HIV-Associated Kaposi’s Sarcoma with a High CD4 Count and a Low Viral Load. New England Journal of Medicine, 357, 1352-1353. https://doi.org/10.1056/NEJMc070508
|
[15]
|
Schneider, J.W. and Dittmer, D.P. (2017) Diagnosis and Treatment of Kaposi Sarcoma. American Journal of Clinical Dermatology, 18, 529-539. https://doi.org/10.1007/s40257-017-0270-4
|
[16]
|
Radu, O. and Pantanowitz, L. (2013) Kaposi Sarcoma. Archives of Pathology & Laboratory Medicine, 137, 289-294.
https://doi.org/10.5858/arpa.2012-0101-RS
|
[17]
|
Dupin, N., Jary, A., Boussouar, S., et al. (2021) Current and Fu-ture Tools for Diagnosis of Kaposi’s Sarcoma. Cancers, 13, Article No. 5927. https://doi.org/10.3390/cancers13235927
|
[18]
|
Grabar, S. and Costagliola, D. (2021) Epidemiology of Kaposi’s Sarcoma. Cancers, 13, Article No. 5692.
https://doi.org/10.3390/cancers13225692
|
[19]
|
Lebbe, C., Garbe, C., Stratigos, A.J., et al. (2019) Diagnosis and Treatment of Kaposi’s Sarcoma: European Consensus-Based Interdisciplinary Guideline (EDF/EADO/EORTC). Euro-pean Journal of Cancer, 114, 117-127.
https://doi.org/10.1016/j.ejca.2018.12.036
|
[20]
|
Reid, E., Suneja, G., Ambinder, R.F., et al. (2019) AIDS-Related Kaposi Sarcoma, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehen-sive Cancer Network, 17, 171-189.
https://doi.org/10.6004/jnccn.2019.0100
|
[21]
|
Ramaswami, R., Polizzotto, M.N., Lurain, K., et al. (2022) Safety, Activity, and Long-term Outcomes of Pomalidomide in the Treatment of Kaposi Sarcoma among Individuals with or without HIV Infection. Clinical Cancer Research, 28, 840-850. https://doi.org/10.1158/1078-0432.CCR-21-3364
|
[22]
|
Reid, E.G., Shimabukuro, K.A., Moore, P., et al. (2022) AMC-070: Lenalidomide Is Safe and Effective in HIV-Associated Kaposi Sarcoma. Clinical Cancer Research, 28, 2646-2656.
https://doi.org/10.1158/1078-0432.CCR-21-0645
|
[23]
|
Alomari, N. and Totonchy, J. (2020) Cytokine-Targeted Therapeutics for KSHV-Associated Disease. Viruses, 12, Article No. 1097. https://doi.org/10.3390/v12101097
|
[24]
|
Ngalamika, O., Mukasine, M.C., Kawimbe, M. and Vally, F. (2021) Viral and Immunological Markers of HIV-Associated Kaposi Sarcoma Recurrence. PLOS ONE, 16, e0254177.
https://doi.org/10.1371/journal.pone.0254177
|
[25]
|
Tuncer, S.B., Celik, B., Akdeniz Odemis, D., et al. (2022) MiRNA Sequence Analysis in Patients with Kaposi’s Sarcoma-Associated Herpesvirus. Pathology and Oncology Re-search, 28, Article ID: 1610055.
https://doi.org/10.3389/pore.2022.1610055
|
[26]
|
Huang, X., Rao, W., Wang, C., et al. (2022) Kaposi’s Sar-coma-Associated Herpes Virus-Derived microRNA K12-1 Over-Activates the PI3K/Akt Pathway to Facilitate Cancer Progression in HIV-Related Gastrointestinal Kaposi’s Sarcoma. SLAS Discovery, 27, 258-265. https://doi.org/10.1016/j.slasd.2022.04.001
|
[27]
|
Lee, S.M., Kaye, K.M. and Slack, F.J. (2021) Cellular mi-croRNA-127-3p Suppresses Oncogenic Herpesvirus-Induced Transformation and Tumorigenesis via Down-Regulation of SKP2. Proceedings of the National Academy of Sciences of the United States of America, 118, e2105428118. https://doi.org/10.1073/pnas.2105428118
|
[28]
|
Re, A., Cattaneo, C. and Rossi, G. (2019) HIV and Lymphoma: From Epidemiology to Clinical Management. Mediterranean Journal of Hematology and Infectious Diseases, 11, e2019004. https://doi.org/10.4084/mjhid.2019.004
|
[29]
|
Epeldegui, M., Widney, D.P. and Martínez-Maza, O. (2006) Pathogenesis of AIDS Lymphoma: Role of Oncogenic Viruses and B Cell Activation-Associated Molecular Lesions. Current Opinion in Oncology, 18, 444-448.
https://doi.org/10.1097/01.cco.0000239882.23839.e5
|
[30]
|
Epeldegui, M., Vendrame, E. and Martínez-Maza, O. (2010) HIV-Associated Immune Dysfunction and Viral Infection: Role in the Pathogenesis of AIDS-Related Lymphoma. Immunologic Research, 48, 72-83.
https://doi.org/10.1007/s12026-010-8168-8
|
[31]
|
Epeldegui, M. and Hussain, S.K. (2020) The Role of Microbial Translocation and Immune Activation in AIDS-Associated Non-Hodgkin Lymphoma Pathogenesis: What Have We Learned? Critical Reviews™ in Immunology, 40, 41-51.
https://doi.org/10.1615/CritRevImmunol.2020033319
|
[32]
|
Dolcetti, R., Giagulli, C., He, W., et al. (2015) Role of HIV-1 Matrix Protein P17 Variants in Lymphoma Pathogenesis. Proceedings of the National Academy of Sciences of the United States of America, 112, 14331-14336.
https://doi.org/10.1073/pnas.1514748112
|
[33]
|
Dolcetti, R., Gloghini, A., Caruso, A. and Carbone, A. (2016) A Lymphomagenic Role for HIV beyond Immune Suppression? Blood, 127, 1403-1409. https://doi.org/10.1182/blood-2015-11-681411
|
[34]
|
Caccuri, F., Muraro, E., Gloghini, A., et al. (2019) Lym-phomagenic Properties of a HIV p17 Variant Derived from a Splenic Marginal Zone Lymphoma Occurred in a HIV-Infected Patient. Hematological Oncology, 37, 176-184.
https://doi.org/10.1002/hon.2562
|
[35]
|
Caby, F., Guiguet, M., Weiss, L., et al. (2021) CD4/CD8 Ratio and the Risk of Kaposi Sarcoma or Non-Hodgkin Lymphoma in the Context of Efficiently Treated Human Immunodeficiency Virus (HIV) Infection: A Collaborative Analysis of 20 European Cohort Studies. Clinical Infectious Diseases, 73, 50-59.
https://doi.org/10.1093/cid/ciaa1137
|
[36]
|
李雪芹, 潘子昂, 郑梅竹, 刘晋新, 施欲新, 王杏, 李莉, 叶雯, 胡天丽, 夏爽, 李宏军. 艾滋病合并弥漫大B细胞淋巴瘤和艾滋病合并伯基特淋巴瘤的临床影像特征[J]. 临床放射学杂志, 2020, 39(12): 2532-2536.
|
[37]
|
Kesavan, M., Eyre, T.A. and Collins, G.P. (2019) Front-Line Treatment of High Grade B Cell Non-Hodgkin Lymphoma. Current Hematologic Malignancy Reports, 14, 207-218. https://doi.org/10.1007/s11899-019-00518-8
|
[38]
|
Navarro, J.-T., Ribera, J.-M., Oriol, A., et al. (2001) Influence of Highly Active Anti-Retroviral Therapy on Response to Treatment and Survival in Patients with Acquired Immunodefi-ciency Syndrome-Related Non-Hodgkin’s Lymphoma Treated with Cyclophosphamide, Hydroxydoxorubicin, Vincris-tine and Prednisone. British Journal of Haematology, 112, 909-915. https://doi.org/10.1046/j.1365-2141.2001.02656.x
|
[39]
|
Vaccher, E., Spina, M., di Gennaro, G., et al. (2001) Con-comitant Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Chemotherapy plus Highly Active Antiretroviral Therapy in Patients with Human Immunodeficiency Virus-Related, Non-Hodgkin Lymphoma. Cancer, 91, 155-163.
https://doi.org/10.1002/1097-0142(20010101)91:1<155::AID-CNCR20>3.0.CO;2-B
|
[40]
|
Tan, C.R.C., Barta, S.K., Lee, J., et al. (2018) Combination Antiretroviral Therapy Accelerates Immune Recovery in Patients with HIV-Related Lymphoma Treated with EPOCH: A Comparison within One Prospective Trial AMC034. Leukemia & Lymphoma, 59, 1851-1860. https://doi.org/10.1080/10428194.2017.1403597
|
[41]
|
赵涵, 张坚生, 陈志敏, 刘波, 廖宝林, 蔡卫平, 何浩岚. 艾滋病相关非霍奇金淋巴瘤38例治疗及预后分析[J]. 肿瘤学杂志, 2020, 26(10): 902-906.
|
[42]
|
Stebbing, J., Marvin, V. and Bower, M. (2004) The Evidence-Based Treatment of AIDS-Related Non-Hodgkin’s Lymphoma. Cancer Treatment Reviews, 30, 249-253. https://doi.org/10.1016/j.ctrv.2003.12.004
|
[43]
|
Li, X., Pan, Z., Wang, X., et al.(2021) Prognostic Nomogram In-corporating Radiological Features for Predicting Overall Survival in Patients with AIDS-Related Non-Hodgkin Lym-phoma. Chinese Medical Journal, 135, 70-78.
https://doi.org/10.1097/CM9.0000000000001785
|
[44]
|
Bower, M., Stebbing, J., Tuthill, M., et al. (2008) Immuno-logic Recovery in Survivors Following Chemotherapy for AIDS-Related Non-Hodgkin Lymphoma. Blood, 111, 3986-3990. https://doi.org/10.1182/blood-2007-10-115659
|
[45]
|
Hernández-Ramírez, R.U., Shiels, M.S., Dubrow, R. and Engels, E.A. (2017) Cancer Risk in HIV-Infected People in the USA from 1996 to 2012: A Population-Based, Registry-Linkage Study. The Lancet HIV, 4, e495-e504.
https://doi.org/10.1016/S2352-3018(17)30125-X
|
[46]
|
Shebl, F.M., Engels, E.A., Goedert, J.J. and Chaturvedi, A.K. (2010) Pulmonary Infections and Risk of Lung Cancer among Persons with AIDS. Journal of Acquired Immune Deficiency Syndromes, 55, 375-379.
https://doi.org/10.1097/QAI.0b013e3181eef4f7
|
[47]
|
Smith, D.M., Salters, K.A., Eyawo, O., et al. (2004) Mortality among People Living with HIV/AIDS with Non-Small-Cell Lung Cancer in the Modern HAART Era. AIDS Care, 30, 936-942.
https://doi.org/10.1080/09540121.2018.1434120
|
[48]
|
da Silva Neto, M.M., Brites, C. and Borges, Á.H. (2020) Cancer during HIV Infection. APMIS, 128, 121-128.
https://doi.org/10.1111/apm.13020
|
[49]
|
European AIDS Clinical Society (2019) European Guidelines for Treat-ment of HIV-Infected Adults in Europe.
|
[50]
|
British HIV Association (2019) BHIVA Guidelines for the Routine In-vestigation and monitoring of Adult HIV-1-Positive Individuals. https://www.bhiva.org/file/DqZbRxfzlYtLg/Monitoring-Guidelines.pdf
|
[51]
|
Brazilian Ministry of Health (2018) Protocolo Clınico e Diretrizes Terap^euticas para Manejo da Infeccao pelo HIV em Adultos. (In Portu-guese)
|
[52]
|
World Health Organization (2017) Consolidated Guideline on Sexual and Reproductive Health and Rights of Women Living with HIV. https://apps.who.int/iris/bitstream/handle/10665/254885/9789241549998-eng.pdf?sequence=1
|
[53]
|
Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV.
|
[54]
|
Yarchoan, R. and Uldrick, T.S. (2018) HIV-Associated Cancers and Related Diseases. New England Journal of Medicine, 378, 1029-1041. https://doi.org/10.1056/NEJMra1615896
|
[55]
|
Lowy, D.R. and Schiller, J.T. (2006) Prophylactic Human Papillo-mavirus Vaccines. Journal of Clinical Investigation, 116, 1167-1173. https://doi.org/10.1172/JCI28607
|
[56]
|
Wilkin, T., Lee, J.Y., Lensing, S.Y., et al. (2010) Safety and Immunogenicity of the Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Men. The Journal of Infectious Diseases, 202, 1246-1253.
https://doi.org/10.1086/656320
|
[57]
|
Castilho, J.L., Bian, A., Jenkins, C.A., et al. (2022) CD4/CD8 Ratio and Can-cer Risk among Adults with HIV. Journal of the National Cancer Institute, 114, 854-862. https://doi.org/10.1093/jnci/djac053
|
[58]
|
Nagata, N., Nishijima, T., Niikura, R., et al. (2018) Increased Risk of Non-AIDS-Defining Cancers in Asian HIV-Infected Patients: A Long-Term Cohort Study. BMC Cancer, 18, Article No. 1066.
https://doi.org/10.1186/s12885-018-4963-8
|
[59]
|
Chiao, E.Y., Coghill, A., Kizub, D., et al. (2021) The Effect of Non-AIDS-Defining Cancers on People Living with HIV. The Lancet Oncology, 22, e240-e253. https://doi.org/10.1016/S1470-2045(21)00137-6
|
[60]
|
Lascar, R.M., Lopes, A.R., Gilson, R.J., et al. (2005) Effect of HIV Infection and Antiretroviral Therapy on Hepatitis B Virus (HBV)—Specific T Cell Responses in Patients Who Have Resolved HBV Infection. The Journal of Infectious Diseases, 191, 1169-1179. https://doi.org/10.1086/428502
|
[61]
|
Hu, J., Liu, K. and Luo, J. (2019) HIV-HBV and HIV-HCV Coinfection and Liver Cancer Development. Cancer Research and Treatment, 177, 231-250. https://doi.org/10.1007/978-3-030-03502-0_9
|
[62]
|
中华医学会感染病学分会艾滋病丙型肝炎学组, 中国疾病预防控制中心. 中国艾滋病诊疗指南(2021年版) [J]. 协和医学杂志, 2021, 39(12): 715-735.
|
[63]
|
Ye, F., Zeng, Y., Sha, J., et al. (2016) High Glucose Induces Reactivation of Latent Kaposi’s Sarcoma-Associated Herpesvirus. Jour-nal of Virology, 90, 9654-9663. https://doi.org/10.1128/JVI.01049-16
|
[64]
|
Aneja, K.K. and Yuan, Y. (2017) Reac-tivation and Lytic Replication of Kaposi’s Sarcoma-Associated Herpesvirus: An Update. Frontiers in Microbiology, 8, Article No. 613. https://doi.org/10.3389/fmicb.2017.00613
|
[65]
|
Pettit, A.C., Giganti, M.J., Ingle, S.M., et al. (2018) Increased Non-AIDS Mortality among Persons with AIDS-Defining Events after Antiretroviral Therapy Initiation. Journal of the International AIDS Society, 21, e25031.
https://doi.org/10.1002/jia2.25031
|